Back to discover
Drug

Cytosine

Research stage
Emerging research
RxNorm1372540ChEMBLCHEMBL15913UNII8J337D1HZY
4
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Cytosine
RxNorm CUI
1372540
ChEMBL ID
CHEMBL15913
UNII
8J337D1HZY

Research activity

4 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20232024
Major research themes8
Gene Editing3CRISPR-Cas Systems1DNA Damage1DNA Repair1DNA, Mitochondrial1Fabaceae1Genome, Mitochondrial1Herbicides1
Journals, researchers & institutions
Top journals
  • BMC biology1
  • Human gene therapy1
  • Nature communications1
  • Plant biotechnology journal1
Leading researchers
  • Bae S1
  • Boch J1
  • Castillo SR1
  • Cha HJ1
  • Clark KJ1
  • Dai X1
  • Devaux P1
  • Dong W1
Leading institutions
free-text, unnormalised
  • Cancer Research Institute1
  • College of Pharmacy1
  • College of Pharmacy and Research Institute of Pharmaceutical Sciences1
  • Dell Medical School1
  • Genomic Medicine Institute1
  • Henan Academy of Crops Molecular Breeding/Key Laboratory of Oil Crops in Huang-huai-hai Plains1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature